Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Anna Health, LLC
WARNING LETTER
•Anna Health, LLC•March 30, 2021

Anna Health, LLC – FDA Warning Letter, Mar 30, 2021

Record Details

The FDA reviewed Anna Health's website (annahealth.com) from October 2020 to March 2021 and determined that products including Fucoidan, Prostate Health, Children Liquid Vitamins, and Immune Health are marketed with claims establishing them as unapproved new drugs. Specifically, the Immune Health product is intended to mitigate, prevent, treat, diagnose, or cure COVID-19.

These products are deemed "drugs" under section 201(g)(1)(B) of the Act due to their intended use in disease cure, mitigation, treatment, or prevention. They are also "new drugs" under section 201(p) because they are not generally recognized as safe and effective for their claimed uses. Introducing or delivering these new drugs into interstate commerce without prior FDA approval violates sections 301(d) and 505(a) of the Act.

Furthermore, the products are misbranded under section 502(f)(1) of the Act because they lack adequate directions for use by a layperson. As they are intended for conditions not amenable to self-diagnosis or treatment, safe use requires supervision by a licensed practitioner, making it impossible to provide adequate directions for lay use. The introduction of these misbranded drugs into interstate commerce violates section 301(a) of the Act.

Anna Health must notify the FDA in writing within 15 working days of receipt of the letter

Company
Anna Health, LLC
Inspection date
March 30, 2021
Product type
Food
Office
Division of Human and Animal Food Operations - East IV
Person
  • Ramon A. Hernandez (Program Director)
View Company Profile

ID · 9ec9fd3e-0197-412a-a221-4602e9686c58

Violation Codes8
21 U.S.C. 321(g)(1)(B)21 U.S.C. 321(p)21 U.S.C. 331(d)21.U.S.C. 355(a)21 U.S.C. 352(f)(1)21 CFR 201.521 U.S.C. 353(b)(1)(A)21 U.S.C. 331(a)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Anna Health, LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.